When complex financial problems arise, Gleason Experts helps clients minimize risk exposure, consider alternative scenarios, project results and take advantage of strategic opportunities.
Gleason IP takes a client-focused, cost-effective approach to IP issues, delivering insightful economic and financial analyses across a range of industries, with particular knowledge/expertise in Pharma/Life Sciences.
Gleason Trust has decades of experience in trust accounting, trust management and administration, and providing high-quality service to meet the fiduciary needs of a variety of trusts.
Gleason Advisors provides valuable financial and strategic advice to closely held, private companies throughout the business life cycle. Our experience spans multiple industries and challenges.
Gleason IP provided expert testimony on behalf of Teva Pharmaceuticals to establish that the asserted patent claims allegedly covering Adapt Pharma’s opioid overdose drug were invalid due to obviousness, and that the marketplace performance of Narcan® was attributable to features already known in the prior art, among other extrinsic factors unrelated to the Patents-in-Suit. Engagement In... Read More
The COVID-19 pandemic and related stay-at-home directives have led to an increase in remote depositions. Historically, attorneys have been reluctant to conduct remote depositions, but there can be certain advantages to be gained from their adoption. On several occasions, Gleason Managing Directors have been deposed virtually and are providing insight for consideration to aid in... Read More